APA (7th ed.) Citation

Rehues, P., Girona, J., Guardiola, M., Plana, N., Scicali, R., Piro, S., . . . Ribalta, J. (2023). PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. International journal of molecular sciences, 24(3), 2319. https://doi.org/10.3390/ijms24032319

Chicago Style (17th ed.) Citation

Rehues, Pere, et al. "PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or Very High Cardiovascular Risk." International Journal of Molecular Sciences 24, no. 3 (2023): 2319. https://doi.org/10.3390/ijms24032319.

MLA (9th ed.) Citation

Rehues, Pere, et al. "PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or Very High Cardiovascular Risk." International Journal of Molecular Sciences, vol. 24, no. 3, 2023, p. 2319, https://doi.org/10.3390/ijms24032319.